Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah G Hirtz

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Pediatrics|November 19, 2002
Regulatory and ethical issues in the conduct of clinical research involving childrenDeborah G Hirtz, Lorraine G Fitzsimmons
Pediatric Neurology|June 13, 2006
Pediatric stroke: Opportunities and challenges in planning clinical trialsSteven G Pavlakis, Deborah G Hirtz, Gabrielle DeVeber
Pediatrics|January 5, 2002
Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood strokeJohn Kylan Lynch, Deborah G Hirtz, Gabrielle DeVeber, et al.
Pediatric Neurology|June 13, 2006
Clinical trials in children--How are they implemented?Deborah G Hirtz, Peter R Gilbert, Cindy M Terrill, et al.
Epilepsia|November 22, 2012
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 monthsTracy A Glauser, Avital Cnaan, Shlomo Shinnar, et al.
Neurology|December 18, 2016
Second monotherapy in childhood absence epilepsyAvital Cnaan, Shlomo Shinnar, Ravindra Arya, et al.
Neurology|October 4, 2013
Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsyDavid Masur, Shlomo Shinnar, Avital Cnaan, et al.
The New England Journal of Medicine|March 5, 2010
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsyTracy A Glauser, Avital Cnaan, Shlomo Shinnar, et al.
Neurology|August 28, 2015
Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trialShlomo Shinnar, Avital Cnaan, Fengming Hu, et al.
Neurology|September 17, 2017
Pretreatment behavior and subsequent medication effects in childhood absence epilepsyRuth C Shinnar, Shlomo Shinnar, Avital Cnaan, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Pediatrics|November 19, 2002
Regulatory and ethical issues in the conduct of clinical research involving childrenDeborah G Hirtz, Lorraine G Fitzsimmons
Pediatric Neurology|June 13, 2006
Pediatric stroke: Opportunities and challenges in planning clinical trialsSteven G Pavlakis, Deborah G Hirtz, Gabrielle DeVeber
Pediatrics|January 5, 2002
Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood strokeJohn Kylan Lynch, Deborah G Hirtz, Gabrielle DeVeber, et al.
Pediatric Neurology|June 13, 2006
Clinical trials in children--How are they implemented?Deborah G Hirtz, Peter R Gilbert, Cindy M Terrill, et al.
Epilepsia|November 22, 2012
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 monthsTracy A Glauser, Avital Cnaan, Shlomo Shinnar, et al.
Neurology|December 18, 2016
Second monotherapy in childhood absence epilepsyAvital Cnaan, Shlomo Shinnar, Ravindra Arya, et al.
Neurology|October 4, 2013
Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsyDavid Masur, Shlomo Shinnar, Avital Cnaan, et al.
The New England Journal of Medicine|March 5, 2010
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsyTracy A Glauser, Avital Cnaan, Shlomo Shinnar, et al.
Neurology|August 28, 2015
Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trialShlomo Shinnar, Avital Cnaan, Fengming Hu, et al.
Neurology|September 17, 2017
Pretreatment behavior and subsequent medication effects in childhood absence epilepsyRuth C Shinnar, Shlomo Shinnar, Avital Cnaan, et al.
Pageof 2